March 10, 2021 Hematological Cancers HEMATOLOGICAL CANCERS AXL signaling Investigational Treatment for Relapsed or Refractory Acute Myeloid Leukemia (AML) Acute myeloid leukemia, bone marrow, small molecule inhibitor, FLT3 signaling Prev Next